V014-3664 Screening compound: 1-{4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzoyl}-2-methylpiperidine

V014-3664 Screening compound: 1-{4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzoyl}-2-methylpiperidine
V014-3664 Screening compound: 1-{4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzoyl}-2-methylpiperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound V014-3664
1-{4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzoyl}-2-methylpiperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V014-3664

Molecular Formula

C26H26FN5O2 (C26 H26 FN5 O2)

Compound Name

1-{4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzoyl}-2-methylpiperidine

IUPAC name

1-{4-[5-(4-fluorophenyl)-4-methyl-3-(5-methyl-134-oxadiazol-2-yl)-1H-pyrazol-1-yl]benzoyl}-2-methylpiperidine

SMILES

CC(CCCC1)N1C(c(cc1)ccc1-n(c(-c(cc1)ccc1F)c1C)nc1-c1nnc(C)o1)=O

InChI

InChI=1S/C26H26FN5O2/c1-16-6-4-5-15-31(16)26(33)20-9-13-22(14-10-20)32-24(19-7-11-21(27)12-8-19)17(2)23(30-32)25-29-28-18(3)34-25/h7-14,16H,4-6,15H2,1-3H3/t16-/m0/s1

InChI Key

ZOPVTEHJQKMPLW-INIZCTEOSA-N

MDL Number (MFCD)

MFCD19948213

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

459.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.999

Distribution Coefficient, logD

3.999

Water Solubility, LogSw

-4.04

Polar Surface Area

59.285

Acid Dissociation Constant (pKa)

23.05

Base Dissociation Constant (pKb)

0.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.80

V014-3664 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

PD-1/L1 Library (498 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
  • Cancer
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Mechanism of action:
  • PPI modulators
Targets:
  • Others

References: we are preparing a list of scientific research reports with V014-3664 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V014-3664?
Check Price and Availability of V014-3664, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V014-3664 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V014-3664
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V014-3664
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V014-3664 available by request